BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34485881)

  • 1. Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF.
    Fossdal G; Mjelle AB; Wiencke K; Bjørk I; Gilja OH; Folseraas T; Karlsen TH; Rosenberg W; Giil LM; Vesterhus M
    JHEP Rep; 2021 Oct; 3(5):100328. PubMed ID: 34485881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
    Eaton JE; Nelson KM; Gossard AA; Carey EJ; Tabibian JH; Lindor KD; LaRusso NF
    Scand J Gastroenterol; 2019 May; 54(5):633-639. PubMed ID: 31131678
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of ElastPQ point-shear wave elastography in the work-up of patients with primary sclerosing cholangitis.
    Roccarina D; Saffioti F; Rosselli M; Marshall A; Pinzani M; Thorburn D
    JHEP Rep; 2023 Nov; 5(11):100873. PubMed ID: 37771366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis.
    Trivedi PJ; Muir AJ; Levy C; Bowlus CL; Manns MP; Lu X; Crans G; Chung C; Subramanian GM; Myers RP; Goodman Z; Chalasani N; Vierling JM; Guha IN; Hirschfield GM
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1248-1257. PubMed ID: 32707342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Elastography in Primary Sclerosing Cholangitis Patients Using Three Different Scanner Systems.
    Mjelle AB; Fossdal G; Gilja OH; Vesterhus M
    Ultrasound Med Biol; 2020 Aug; 46(8):1854-1864. PubMed ID: 32507342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis.
    Trauner M; Gindin Y; Jiang Z; Chung C; Subramanian GM; Myers RP; Gulamhusein A; Kowdley KV; Levy C; Goodman Z; Manns MP; Muir AJ; Bowlus CL
    JHEP Rep; 2020 Feb; 2(1):100060. PubMed ID: 32039401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
    de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
    Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.
    Vesterhus M; Hov JR; Holm A; Schrumpf E; Nygård S; Godang K; Andersen IM; Naess S; Thorburn D; Saffioti F; Vatn M; Gilja OH; Lund-Johansen F; Syversveen T; Brabrand K; Parés A; Ponsioen CY; Pinzani M; Färkkilä M; Moum B; Ueland T; Røsjø H; Rosenberg W; Boberg KM; Karlsen TH
    Hepatology; 2015 Jul; 62(1):188-97. PubMed ID: 25833813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
    Taneja S; Mehtani R; De A; Mitra S; Rathi S; Verma N; Premkumar M; Minz R; Duseja A; Das A; Singh V; Dhiman RK; Chawla YK
    J Clin Exp Hepatol; 2023; 13(2):241-251. PubMed ID: 36950480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embedding assessment of liver fibrosis into routine diabetic review in primary care.
    Mansour D; Grapes A; Herscovitz M; Cassidy P; Vernazza J; Broad A; Anstee QM; McPherson S
    JHEP Rep; 2021 Aug; 3(4):100293. PubMed ID: 34179738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.
    Farahmand F; Ahmadi M; Khodadad A; Najafi M; Fallahi G; Motamed F; Movahedi M; Aghamohammadi A; Rezaei N; Javaherizadeh H
    Clin Exp Hepatol; 2019 Nov; 5(4):285-288. PubMed ID: 31893239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term prognostic factors for primary sclerosing cholangitis.
    Watanabe T; Hirano K; Tada M; Isayama H; Mizuno S; Arizumi T; Toda N; Sugawara Y; Kokudo N; Koike K
    J Hepatobiliary Pancreat Sci; 2015 Jun; 22(6):486-90. PubMed ID: 25826613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
    Trauner M; Gulamhusein A; Hameed B; Caldwell S; Shiffman ML; Landis C; Eksteen B; Agarwal K; Muir A; Rushbrook S; Lu X; Xu J; Chuang JC; Billin AN; Li G; Chung C; Subramanian GM; Myers RP; Bowlus CL; Kowdley KV
    Hepatology; 2019 Sep; 70(3):788-801. PubMed ID: 30661255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Elastography in Primary Sclerosing Cholangitis: Interobserver Agreement for Liver Stiffness Measurement with Manual and Automated Methods.
    Hoodeshenas S; Welle CL; Navin PJ; Dzyubak B; Eaton JE; Ehman RL; Venkatesh SK
    Acad Radiol; 2019 Dec; 26(12):1625-1632. PubMed ID: 30878345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound and Point Shear Wave Elastography in Livers of Patients with Primary Sclerosing Cholangitis.
    Mjelle AB; Mulabecirovic A; Hausken T; Havre RF; Gilja OH; Vesterhus M
    Ultrasound Med Biol; 2016 Sep; 42(9):2146-55. PubMed ID: 27262519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis.
    Liu X; Wang H; Liu X; Bridle K; Crawford D; Liang X
    Pharmacol Ther; 2022 Sep; 237():108163. PubMed ID: 35271884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.